Clinical outcomes of State-of-the-Art percutaneous coronary revascularization in patients with de novo three vessel disease: Results of the SYNTAX II trial.

26 August 2017 (00:00 - 00:00)

Organised by:

Sign in for access options

ESC TV

Sign in for access options

Sign in for access options

About the speaker

Professor Javier Escaned

San Carlos Clinical Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail

Comparison of titanium-nitride-oxide-coated versus everolimus-eluting stents in acute coronary syndrome

Doctor P. Tonino (Eindhoven, NL)

Presentation thumbnail

A Multicenter, Randomized-Controlled, Blinded Trial of Drug-Eluting vs. Bare Metal Stents in De Novo Saphenous Vein Graft Lesions

Mr E. Brilakis (Minneapolis, US)

Presentation thumbnail

Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized controlled trial

Professor M. Hong (Seoul, KR)

Presentation thumbnail

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention and Survival in Patients with Type 1 Diabetes Mellitus

Doctor M. Holzmann (Stockholm, SE)

Presentation thumbnail

Five-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Doctor M. Natsuaki (Saga, JP)

Access the full session

Session thumbnail

Late-Breaking Science in PCI 1

The Event

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources